Annual report [Section 13 and 15(d), not S-K Item 405]

Segment Information (Tables)

v3.26.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Information
The following table is a summary of segment information for Fiscal 2025 and 2024 (in thousands):
For the years ended
December 31, 2025 December 31, 2024
Net revenues
Diagnostic services $ —  $ — 
Consumer products 4,345  6,770 
Consolidated net revenue 4,345  6,770 
Cost of revenue    
Diagnostic services 351  2,329 
Consumer products 2,610  4,591 
Consolidated cost of revenue 2,961  6,920 
Depreciation and amortization expense    
Diagnostic services 614  1,604 
Consumer products 1,636  4,583 
Total Depreciation and amortization expense 2,250  6,187 
Operating and other expenses
 Diagnostic services 2,891  15,928 
 Consumer products 5,587  4,484 
 Unallocated corporate 14,043  15,581 
 Total operating and other expenses 22,521  35,993 
Loss from operations, before income taxes    
Diagnostic services (3,856) (19,861)
Consumer products (5,488) (6,888)
Unallocated corporate (14,043) (15,581)
 Total loss from operations, before income taxes (23,387) (42,330)
Income tax expense —  (7,195)
 Net loss from continuing operations $ (23,387) $ (49,525)
The following table is a summary of segment information for Fiscal 2025 and Fiscal 2024 (in thousands):
December 31,
2025
December 31,
2024
ASSETS  
Diagnostic services $ —  $ 26,069 
Consumer products 11,614  19,745 
Unallocated corporate 48,257  5,804 
 Assets held-for-sale —  11,582 
Total assets $ 59,871  $ 63,200